Publications

Articles

Chronic kidney disease is the key risk factor for severe COVID-19. A call to action by the European Renal Association

Ortiz A, Cozzolino M, Duivenvoorden R, Fliser D, Fouque D, Franssen CFM, Goumenos, D, Hemmelder M, Hilbrands LB, Jager KJ, Massy ZA, Noordzij M, Rosenkranz A, Rychlik I, Soler MJ, Stevens K, Torra R, Tuglular S, Vart P,  Gansevoort RT.

Nephrol Dial Transplant 2020 (in press). Preliminary version:

 

 

COVID-19 related mortality in kidney transplant and dialysis patients. Results of              the ERACODA Collaboration

Hilbrands LB, Duivenvoorden R, Franssen CFM, Hemmelder MH, Jager KJ, Kieneker LM, Pena MJ, de Vries                H, Arroyo D, Covic A, Crespo M, Goffin E, Islam M, Massy ZA, Montero N, Oliveira JP, Roca Muñoz A,         

Sanchez JE, Sridharan S, Winzeler R, Gansevoort RT, ERACODA Collaborators

Nephrol Dial Transplant 2020; 35: 1973-1983. doi: 10.1093/ndt/gfaa261.

Chronic kidney disease, the risk factor for COVID-19 mortality

Gansevoort RT and Hilbrands LB

Nat Rev Nephrol 2020; 26:1-2. doi: 10.1038/s41581-020-00349-4.

ERACODA: The European database collecting clinical information of patients on              kidney replacement therapy with COVID-19

Noordzij M, Duivenvoorden R, Franssen CFM, Hemmelder MH, Hilbrands LB, Jager KJ, Kieneker LM, Pena               MJ, de Vries H, Gansevoort RT

Nephrol Dial Transplant 2020 (in press). doi: 10.1093/ndt/gfaa179. 

         

Study Reports

     ERACODA Study Report 5

     ERACODA Study Report 4

     ERACODA Study Report 3

     ERACODA Study Report 2

     ERACODA Study Report 1

Presentations

       Prognosis and risk factors for mortality in patients on KRT with COVID-19

      Ron T. Gansevoort

      ERA-EDTA Virtual Congress 2020. A recording of the presentation can be viewed here.  

       The transplant patient at risk?

      Luuk Hilbrands

      ERA-EDTA Virtual Congress 2020. A recording of the presentation can be viewed here.

     

Contact Us

If you want to collaborate, or if you have any questions about ERACODA or suggestions for future research, please contact us at COVID.19.KRT@umcg.nl.